Cargando…
LPPR5 Expression in Glioma Affects Growth, Vascular Architecture, and Sunitinib Resistance
Despite intensive research, glioblastoma remains almost invariably fatal. Various promising drugs targeting specific aspects of glioma biology, in addition to or as an alternative to antiproliferative chemotherapy, were not successful in larger clinical trials. Further insights into the biology of g...
Autores principales: | Stange, Lena, Lucia, Kristin Elizabeth, Ghori, Adnan, Vajkoczy, Peter, Czabanka, Marcus, Broggini, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952597/ https://www.ncbi.nlm.nih.gov/pubmed/35328529 http://dx.doi.org/10.3390/ijms23063108 |
Ejemplares similares
-
Endothelial EphrinB2 Regulates Sunitinib Therapy Response in Murine Glioma
por: Broggini, Thomas, et al.
Publicado: (2022) -
EphB4 mediates resistance to antiangiogenic therapy in experimental glioma
por: Uhl, Christian, et al.
Publicado: (2018) -
Role of mTOR and VEGFR Inhibition in Prevention of Metastatic Tumor Growth in the Spine
por: Kratzsch, Tobias, et al.
Publicado: (2020) -
Plasticity-related gene 3 (LPPR1) and age at diagnosis of Parkinson disease
por: Wallen, Zachary D., et al.
Publicado: (2018) -
EphrinB2–EphB4 Signaling in Neurooncological Disease
por: Piffko, Andras, et al.
Publicado: (2022)